12th International Workshop on Waldenström’s Macroglobulinemia
Prague Marriott Hotel
Prague, Czech Republic
October 17-20, 2024
Attend the world’s most comprehensive hematology/oncology event on Waldenstrom’s macroglobulinemia; the 12th International Workshop on Waldenstrom’s macroglobulinemia (IWWM-12).
The 12th International Workshop for Waldenstrom's Macroglobulinemia is being held October 17th to October 20th, 2024 in Prague, Czech, Republic. The venue chosen for this meeting is one of Prague’s premier hotels, Prague Marriot Hotel, located in the old city of Prague . The hotel nestles in one of the city’s most historic areas nearby the city’s most enriching museums, vibrant parks and gardens, and epicurean eateries.Onsite registration and check-in will be from 14:00 (2:00pm) to 18:00 (6:00pm) on Wednesday, October 16th, conference sessions starting on Thursday, the 17th, at 8:00am.
The Workshop’s mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic system, by promoting targeted research, clinical care methods, education, training, and advocacy for Waldenstrom’s macroglobulinemia.
IWWM-12 will continue to support future research by including a Junior Investigator Poster presentation event with short oral presentations. Abstract submissions for poster presentations will begin in May 2024.
We expect this international Workshop to be as comprehensive as IWWM-11, which included 20 sessions with over 90 technical presentations. Since the IWWM began in 2000, the number of participating international investigators has steadily grown to over 30 countries, and over 8,600 publications including those created and developed from the IWWM Workshops. These publications have been published in the New England Journal of Medicine, Blood, Clinical Lymphoma Myeloma, Haematologica, Journal of Clinical Oncology, Leukemia, Nature, Lancet, and other top publications.
The IWWM-12 workshops will continue the mission to enrich each attendee’s understanding and help foster research discoveries and lifetime collaborations leading to more effective treatments and ultimately find a cure for Waldenstrom's macroglobulinemia.
We look forward to welcoming you to the Workshop!
Workshop Chairs

Christian Buske, MD, PhD
Institute of Experimental Cancer Research
Ulm University
Ulm, Germany
Ulm University
Ulm, Germany

Steven Treon, MD, PhD
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA, USA
Harvard Medical School
Boston, MA, USA

Jeffrey Matous, MD
Colorado Blood Cancer Institute
Denver, Colorado
Denver, Colorado

Chris Patterson - Secretariat
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA, USA
Harvard Medical School
Boston, MA, USA
Scientific Committee
Ranjana Advani, MD (USA)
Xinxin Cao, MD (China)
Jorge Castillo, MD (USA)
Christian Buske MD, PhD (Germany)
Ramón García Sanz MD, PhD (Spain)
Prashant Kapoor, MD (USA)
Efstathios Kastritis, MD, PhD (Greece)
Xinxin Cao, MD (China)
Jorge Castillo, MD (USA)
Christian Buske MD, PhD (Germany)
Ramón García Sanz MD, PhD (Spain)
Prashant Kapoor, MD (USA)
Efstathios Kastritis, MD, PhD (Greece)
Marie Jóse Kersten, MD, PhD (Netherlands)
Lugui Qiu, MD (China)
Naohiro Sekiguchi, MD, PhD (Japan)
Constantine Tam, MD, FRACP, FRCPA (Australia)
Alessandra Tedeschi, MD (Italy)
Judith Trotman, MD, FRACP, FRCPA (Australia)
Marzia Varettoni, MD (Italy)
Lugui Qiu, MD (China)
Naohiro Sekiguchi, MD, PhD (Japan)
Constantine Tam, MD, FRACP, FRCPA (Australia)
Alessandra Tedeschi, MD (Italy)
Judith Trotman, MD, FRACP, FRCPA (Australia)
Marzia Varettoni, MD (Italy)